Hijazi, Z., Oldgren, J., Lindbaeck, J., Alexander, J. H., Hanna, M., Hylek, E. M., … Wallentin, L. (2016). Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial. In CIRCULATION (Vol. 134).

Hijazi, Ziad, Jonas Oldgren, Johan Lindbaeck, John H. Alexander, Michael Hanna, Elaine M. Hylek, Renato D. Lopes, Christopher B. Granger, Agneta Siegbahn, and Lars Wallentin. “Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial.” In CIRCULATION, Vol. 134, 2016.

Hijazi Z, Oldgren J, Lindbaeck J, Alexander JH, Hanna M, Hylek EM, et al. Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial. In: CIRCULATION. 2016.

Hijazi, Ziad, et al. “Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial.” CIRCULATION, vol. 134, 2016.

Hijazi Z, Oldgren J, Lindbaeck J, Alexander JH, Hanna M, Hylek EM, Lopes RD, Granger CB, Siegbahn A, Wallentin L. Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial. CIRCULATION. 2016.